Skip to content

Drug interactions

Pazopanib + Vorinostat

Severity: Major

Pazopanib and Vorinostat: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs have been associated with QT prolongation, so combined use may increase the risk of torsades de pointes. Risk is higher with electrolyte disturbances or structural heart disease.

What this interaction means in plain words

Pazopanib and Vorinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Pazopanib belongs to Oncology; Vorinostat belongs to Oncology.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization.

What to do

Obtain baseline ECG and electrolytes and monitor periodically. Correct hypokalemia and hypomagnesemia, and avoid the combination in patients with long QT.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pazopanib and Vorinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pazopanib with Vorinostat?

MediHelp rates the interaction as major. Pazopanib and Vorinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs have been associated with QT prolongation, so combined use may increase the risk of torsades de pointes. Risk is higher with electrolyte disturbances or structural heart disease.

How serious is the interaction between Pazopanib and Vorinostat?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain baseline ECG and electrolytes and monitor periodically. Correct hypokalemia and hypomagnesemia, and avoid the combination in patients with long QT.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in